The oncogene BRAFV600E is associated with a high risk of recurrence and less differentiated papillary thyroid carcinoma due to the impairment of Na+/I− targeting to the membrane (Q60559931)
Jump to navigation
Jump to search
scientific article published on 01 March 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The oncogene BRAFV600E is associated with a high risk of recurrence and less differentiated papillary thyroid carcinoma due to the impairment of Na+/I− targeting to the membrane |
scientific article published on 01 March 2006 |
Statements
The oncogene BRAF V600E is associated with a high risk of recurrence and less differentiated papillary thyroid carcinoma due to the impairment of Na+/I- targeting to the membrane (English)
P Gutiérrez-Martínez